This overlooked corner of women's health could be a $350 billion market opportunity
Publishing timestamp: 2024-03-15 14:33:39
Summary
Menopause is gaining more attention in public conversation, with a high unmet need for innovative treatments. Companies like Pfizer, Biote, and others are stepping in to fill the gap with hormone therapy and non-hormone treatments. However, much of the innovation is happening in the private space, and women's health, including menopause, remains underfunded despite the potential for growth and impact.
Sentiment: NEUTRAL
Tickers: VTGN, UNDEFINED, PGNY, DARE, PFE, GOOGL,
Keywords: biotech and pharmaceuticals, diversity & equality, women's health, cerulean pharma inc, business news, pfizer inc, breaking news: investing, progyny inc, pharmaceuticals, science, investment strategy, health care industry, alphabet inc, vistagen therapeutics inc, biote corp, health insurance,